INGR:NYSEIngredion Incorporated Analysis

Ingredion’s share price is hovering just above its nearest support at $100.71, while technical gauges signal a mixed picture: the 14‑day RSI sits at a deep 23, flagging oversold conditions, yet the MACD remains bearish and the stock trades below its 20‑, 50‑ and 200‑day moving averages, underscoring a prevailing downtrend. Low beta (≈0.25) and a 30‑day volatility of ~17% suggest the stock moves less than the market, offering defensive stability, and the dividend yield of 3.23% appears sustainable given a 31% payout ratio and solid free cash flow.
Fundamentally, revenue slipped 1.2% year‑over‑year and Q1 earnings fell sharply, driven by operational setbacks at the Argo facility, though the Texture & Healthful Solutions segment still posted volume growth. The company trades at a modest trailing P/E of 9.75 and forward P/E of 8.74, yet the discounted cash‑flow model pins a fair value near $59, implying the market price of $101 is significantly overvalued. Analysts maintain a “Buy” consensus with a mean target of $122, but the gap between that target and the DCF estimate signals upside risk limited to the near‑term support area. The dividend, low leverage (debt‑to‑equity 41%) and defensive consumer‑staples positioning support a cautious hold, while earnings weakness and the overvalued price suggest prudence.